Charles River Laboratories International (CRL) Share-based Compensation (2009 - 2025)

Charles River Laboratories International's Share-based Compensation history runs 17 years deep, the most recent figure standing at $17.6 million for Q4 2025.

• In Q4 2025, Share-based Compensation rose 2.3% year-over-year to $17.6 million; the TTM figure through Dec 2025 stood at $71.1 million (up 1.71% YoY), while the FY2025 annual figure was $71.1 million, up 1.71% from the prior year.
• Share-based Compensation for Q4 2025 stood at $17.6 million, down from $23.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $23.3 million in Q3 2025, with the low at $13.1 million in Q1 2025.
• The 5-year median for Share-based Compensation is $17.2 million (2021), against an average of $17.9 million.
• The sharpest annual moves came in 2021 and 2025: Share-based Compensation jumped 30.55% in 2021, then declined 21.53% in 2025.
• Charles River Laboratories International's Share-based Compensation stood at $19.2 million in 2021, then rose by 15.03% to $22.1 million in 2022, then decreased by 11.55% to $19.5 million in 2023, then decreased by 11.71% to $17.2 million in 2024, then advanced by 2.3% to $17.6 million in 2025.
• Business Quant data shows CRL's Share-based Compensation at $17.6 million in Q4 2025, $23.3 million in Q3 2025, and $17.0 million in Q2 2025.